Cannabinoid: Difference between revisions

Line 7:

==Cannabinoid receptors==

Before the 1980s, it was often speculated that cannabinoids produced their physiological and behavioral effects via nonspecific interactions, instead of interacting with specific receptors directly. The discovery of the first cannabinoid receptors in the 1980s helped to resolve this debate. These receptors are common in animals, and have been found in mammals, birds, fish, and reptiles. At present, there are two known types of cannabinoid receptors, termed CB1 and CB2,<ref>The endocannabinoid system as an emerging target of pharmacotherapy | http://www.ncbi.nlm.nih.gov/pubmed/16968947</ref> with mounting evidence of more.<ref>Evidence for novel cannabinoid receptors | The human brain has more cannabinoid receptors than any other G protein-coupled receptor (GPCR) type.</ref><ref>Boron, Walter F.; Boulpaep, Emile L., eds. (2009). Medical Physiology: A Cellular and Molecular Approach. Saunders. p. 331. ISBN 978-1-4160-3115-4. </ref> However, the role of these interactions and how they result in the cannabinoid high experience continues to remain elusive.

Before the 1980s, it was often speculated that cannabinoids produced their physiological and behavioral effects via nonspecific interactions instead of interacting with specific receptors directly. The discovery of the first cannabinoid receptors in the 1980s helped to resolve this debate. These receptors are common in animals and have been found in mammals, birds, fish, and reptiles. At present, there are two known types of cannabinoid receptors, termed CB1 and CB2,<ref>The endocannabinoid system as an emerging target of pharmacotherapy | http://www.ncbi.nlm.nih.gov/pubmed/16968947</ref> with mounting evidence of more.<ref>Evidence for novel cannabinoid receptors | The human brain has more cannabinoid receptors than any other G protein-coupled receptor (GPCR) type.</ref><ref>Boron, Walter F.; Boulpaep, Emile L., eds. (2009). Medical Physiology: A Cellular and Molecular Approach. Saunders. p. 331. ISBN 978-1-4160-3115-4. </ref> However, the role of these interactions and how they result in the cannabinoid high experience continues to remain elusive.

===Cannabinoid receptor type 1===

CB1 receptors are found primarily in the brain, more specifically in the basal ganglia and in the limbic system, including the hippocampus.<ref>The endocannabinoid system as an emerging target of pharmacotherapy | http://www.ncbi.nlm.nih.gov/pubmed/16968947 </ref> They are also found in the cerebellum and in both male and female reproductive systems. CB1 receptors are absent in the medulla oblongata, the part of the brain stem responsible for respiratory and cardiovascular functions. Thus, there is not the risk of respiratory or cardiovascular failure that can be produced by some drugs. CB1 receptors appear to be responsible for the euphoric and anticonvulsive effects of cannabis. However, the role of these interactions and how they result in the cannabinoid high experience continues to remain elusive.

@@ Line 7: / Line 7: @@
 ==Cannabinoid receptors==
-Before the 1980s, it was often speculated that cannabinoids produced their physiological and behavioral effects via nonspecific interactions, instead of interacting with specific receptors directly. The discovery of the first cannabinoid receptors in the 1980s helped to resolve this debate. These receptors are common in animals, and have been found in mammals, birds, fish, and reptiles. At present, there are two known types of cannabinoid receptors, termed CB1 and CB2,<ref>The endocannabinoid system as an emerging target of pharmacotherapy | http://www.ncbi.nlm.nih.gov/pubmed/16968947</ref> with mounting evidence of more.<ref>Evidence for novel cannabinoid receptors | The human brain has more cannabinoid receptors than any other G protein-coupled receptor (GPCR) type.</ref><ref>Boron, Walter F.; Boulpaep, Emile L., eds. (2009). Medical Physiology: A Cellular and Molecular Approach. Saunders. p. 331. ISBN 978-1-4160-3115-4. </ref> However, the role of these interactions and how they result in the cannabinoid high experience continues to remain elusive.
+Before the 1980s, it was often speculated that cannabinoids produced their physiological and behavioral effects via nonspecific interactions instead of interacting with specific receptors directly. The discovery of the first cannabinoid receptors in the 1980s helped to resolve this debate. These receptors are common in animals and have been found in mammals, birds, fish, and reptiles. At present, there are two known types of cannabinoid receptors, termed CB1 and CB2,<ref>The endocannabinoid system as an emerging target of pharmacotherapy | http://www.ncbi.nlm.nih.gov/pubmed/16968947</ref> with mounting evidence of more.<ref>Evidence for novel cannabinoid receptors | The human brain has more cannabinoid receptors than any other G protein-coupled receptor (GPCR) type.</ref><ref>Boron, Walter F.; Boulpaep, Emile L., eds. (2009). Medical Physiology: A Cellular and Molecular Approach. Saunders. p. 331. ISBN 978-1-4160-3115-4. </ref> However, the role of these interactions and how they result in the cannabinoid high experience continues to remain elusive.
 ===Cannabinoid receptor type 1===
 CB1 receptors are found primarily in the brain, more specifically in the basal ganglia and in the limbic system, including the hippocampus.<ref>The endocannabinoid system as an emerging target of pharmacotherapy | http://www.ncbi.nlm.nih.gov/pubmed/16968947 </ref> They are also found in the cerebellum and in both male and female reproductive systems. CB1 receptors are absent in the medulla oblongata, the part of the brain stem responsible for respiratory and cardiovascular functions. Thus, there is not the risk of respiratory or cardiovascular failure that can be produced by some drugs. CB1 receptors appear to be responsible for the euphoric and anticonvulsive effects of cannabis. However, the role of these interactions and how they result in the cannabinoid high experience continues to remain elusive.